Nicox’s Big Bet on Nitric-Oxide Platform

Nicox SA CEO and chairman Michele Garufi describes the company’s glaucoma-focused pipeline, drawing on its nitric-oxide platform. He explains how NO works in animal models and talks about NCX-470 moving into Phase II trials.